These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10071786)

  • 21. Selective opioid dipeptides.
    Temussi PA; Salvadori S; Amodeo P; Bianchi C; Guerrini R; Tomatis R; Lazarus LH; Picone D; Tancredi T
    Biochem Biophys Res Commun; 1994 Feb; 198(3):933-9. PubMed ID: 8117299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inverse agonism and neutral antagonism at wild-type and constitutively active mutant delta opioid receptors.
    Tryoen-Tóth P; Décaillot FM; Filliol D; Befort K; Lazarus LH; Schiller PW; Schmidhammer H; Kieffer BL
    J Pharmacol Exp Ther; 2005 Apr; 313(1):410-21. PubMed ID: 15590769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TIPP[psi]: a highly potent and stable pseudopeptide delta opioid receptor antagonist with extraordinary delta selectivity.
    Schiller PW; Weltrowska G; Nguyen TM; Wilkes BC; Chung NN; Lemieux C
    J Med Chem; 1993 Oct; 36(21):3182-7. PubMed ID: 8230106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attenuation of morphine tolerance and dependence with the highly selective delta-opioid receptor antagonist TIPP[psi].
    Fundytus ME; Schiller PW; Shapiro M; Weltrowska G; Coderre TJ
    Eur J Pharmacol; 1995 Nov; 286(1):105-8. PubMed ID: 8566146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Agonist, antagonist, and inverse agonist characteristics of TIPP (H-Tyr-Tic-Phe-Phe-OH), a selective delta-opioid receptor ligand.
    Martin NA; Ruckle MB; VanHoof SL; Prather PL
    J Pharmacol Exp Ther; 2002 May; 301(2):661-71. PubMed ID: 11961071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic agonist treatment converts antagonists into inverse agonists at delta-opioid receptors.
    Liu JG; Prather PL
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1070-9. PubMed ID: 12183665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short-term inverse-agonist treatment induces reciprocal changes in delta-opioid agonist and inverse-agonist binding capacity.
    Piñeyro G; Azzi M; De Léan A; Schiller P; Bouvier M
    Mol Pharmacol; 2001 Oct; 60(4):816-27. PubMed ID: 11562445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dmt and opioid peptides: a potent alliance.
    Bryant SD; Jinsmaa Y; Salvadori S; Okada Y; Lazarus LH
    Biopolymers; 2003; 71(2):86-102. PubMed ID: 12767112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel TIPP (H-Tyr-Tic-Phe-Phe-OH) analogues displaying a wide range of efficacies at the δ opioid receptor. Discovery of two highly potent and selective δ opioid agonists.
    Berezowska I; Lemieux C; Chung NN; Ding J; Schiller PW
    Bioorg Med Chem Lett; 2012 Mar; 22(5):1899-902. PubMed ID: 22325949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conformation-activity relationships of opioid peptides with selective activities at opioid receptors.
    Hruby VJ; Agnes RS
    Biopolymers; 1999; 51(6):391-410. PubMed ID: 10797229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dmt-Tic-OH a highly selective and potent delta-opioid dipeptide receptor antagonist after systemic administration in the mouse.
    Capasso A; Guerrini R; Balboni G; Sorrentino L; Temussi P; Lazarus LH; Bryant SD; Salvadori S
    Life Sci; 1996; 59(8):PL93-8. PubMed ID: 8761022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of kappa and delta opioid receptors in isolated organs by using type/subtype selective agonists and antagonists.
    Makó E; Rónai AZ
    Med Sci Monit; 2001; 7(3):350-6. PubMed ID: 11386008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new opioid designed multiple ligand derived from the micro opioid agonist endomorphin-2 and the delta opioid antagonist pharmacophore Dmt-Tic.
    Salvadori S; Trapella C; Fiorini S; Negri L; Lattanzi R; Bryant SD; Jinsmaa Y; Lazarus LH; Balboni G
    Bioorg Med Chem; 2007 Nov; 15(22):6876-81. PubMed ID: 17851080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
    J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From the potent and selective mu opioid receptor agonist H-Dmt-d-Arg-Phe-Lys-NH(2) to the potent delta antagonist H-Dmt-Tic-Phe-Lys(Z)-OH.
    Balboni G; Cocco MT; Salvadori S; Romagnoli R; Sasaki Y; Okada Y; Bryant SD; Jinsmaa Y; Lazarus LH
    J Med Chem; 2005 Aug; 48(17):5608-11. PubMed ID: 16107162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A uniform molecular model of delta opioid agonist and antagonist pharmacophore conformations.
    Brandt W
    J Comput Aided Mol Des; 1998 Nov; 12(6):615-21. PubMed ID: 9879509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The receptor-bound conformation of H-Tyr-Tic-(Phe-Phe)-OH-related delta-opioid antagonists contains all trans peptide bonds.
    Wilkes BC; Nguyen TM; Weltrowska G; Carpenter KA; Lemieux C; Chung NN; Schiller PW
    J Pept Res; 1998 May; 51(5):386-94. PubMed ID: 9606018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of hydrophobic substituents in the interaction of opioid Tyr-Tic dipeptide analogs with dodecylphosphocholine micelles. Molecular partitioning in model membrane systems.
    Carpenter KA; Wilkes BC; Weltrowska G; Schiller PW
    Eur J Biochem; 1996 Nov; 241(3):756-64. PubMed ID: 8944763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design of mu selective opioid dipeptide antagonists.
    Capasso A; Amodeo P; Balboni G; Guerrini R; Lazarus LH; Temussi PA; Salvadori S
    FEBS Lett; 1997 Nov; 417(1):141-4. PubMed ID: 9395092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and evaluation of isothiocyanate-containing derivatives of the delta-opioid receptor antagonist Tyr-Tic-Phe-Phe (TIPP) as potential affinity labels for delta-opioid receptors.
    Maeda DY; Berman F; Murray TF; Aldrich JV
    J Med Chem; 2000 Dec; 43(26):5044-9. PubMed ID: 11150176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.